Mayo Clinic
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).
Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.
Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.
Top-decile sponsor footprint
Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
2,844 total, page 30 of 57
Urinary Tract Infections Rates Using 50% Dextrose Plus Washout Versus Normal Saline as Cystoscopy Fluid
NCT03719755
Pediatric NMOSD Observational Study
NCT03766347
Pulmonary Rehabilitation in End-Stage Liver Disease
NCT03266575
Coagulation Test Changes Associated With Acute Normovolemic Hemodilution in Cardiac Surgery
NCT03647644
Augmenting Patching Treatment for Amblyopia With Physical Exercise
NCT03822806
Increasing Adherence to Pulmonary Rehabilitation After COPD Related Hospitalizations (Pilot Study)
NCT03865329
Thromboelastography-Guided Fluid Management in Spinal Surgery
NCT03999086
Abdominal Ice Packs for Pain Control and Reduction of Narcotic Use Following Laparoscopic Hysterectomy
NCT03341533
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
NCT03404661
Performance and Nutrition Program for Athletes in Adaptive Sports
NCT03392155
Statins and CPAP in Adipose Tissue of OSA
NCT03308578
Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors
NCT03237390
Cochlear Promontory Stimulation for Treatment of Tinnitus
NCT03759834
Enhancing Adaptations to Exercise
NCT03350906
Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)
NCT03406975
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
NCT03276832
Mesenchymal Stem Cells Therapy in Patients With Recent Intracerebral Hemorrhage
NCT03371329
TAS-102 and Radiation Therapy in Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, or Cannot Be Removed by Surgery
NCT03297710
Individualized Obesity Pharmacotherapy
NCT03374956
Complications Associated With Primary Placement of Gastrostomy for Feeding
NCT05173935
The TOGETHER Project - Heart
NCT03833050
Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
NCT03270085
Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer
NCT03012230
Impact of Massage Therapy and Music Therapy on the Quality of Life of Hospice Patients
NCT03217682
Connected Health Care in Exercise Program for Obesity
NCT03446235
Transthyretin Cardiac Amyloidosis in HFpEF
NCT03414632
Insulin Deprivation on Brain Structure and Function in Humans With Type 1 Diabetes
NCT03392441
Transcutaneous Submandibular Gland Biopsy: Feasibility of Repeat Biopsy as a Progression Marker for Parkinson's Disease
NCT03359226
Electrophysiological Comparison of mAP and mADM Using EMG
NCT03360825
New Technologies to Determine Carotid Plaque Vulnerability in Patients With Significant Carotid Plaques
NCT03335033
Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis
NCT03269409
Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma
NCT03325101
Characterization of Bile Acid Pathway in Obesity
NCT03341052
Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
NCT06564051
Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides
NCT03281811
Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)
NCT03327623
Assessment of Longitudinal Changes in Endothelial Function and Oxidative Stress in Normotensive Patients With ADPKD
NCT03493802
Staging Prostate Cancer With Hybrid C11-Choline PET/MR and mpMRI
NCT03404648
Mobile Educations Effect on Pain Outcomes
NCT03301610
TAS-102 in Treating Advanced Biliary Tract Cancers
NCT03278106
Wound Necrosis in Lower Extremity Surgery
NCT03351387
Stem Cell Coated Fistula Plug in Patients With Crohn's RVF
NCT03220243
Ultrasound-Guided Costoclavicular Block in Patients With a BMI > 30
NCT03314948
Engineering Gut Microbiome to Target Breast Cancer
NCT03358511
Changes in Intestinal Permeability 4 Hours After Gluten Challenge
NCT03288831
Music Therapy Intervention to Reduce Caregiver Distress at the End of Life
NCT03322228
EPAD Monitoring of Patients Undergoing Robotic Assisted Laparoscopic Genitourinary Surgery
NCT03319407
Efficacy of Penile Traction Therapy Using a Novel Device
NCT03389854
Pneumococcal Vaccines in Patients With Asthma
NCT03260790
Mucosal Impedance Balloon in Diagnosis and Treatment of Eosinophilic Esophagitis (EoE)
NCT02995395
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 435 |
| Phase 2 | 386 |
| Phase 3 | 86 |
| Phase 4 | 166 |
Therapeutic Areas
What is open in the Mayo Clinic pipeline
544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).
Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).
Top condition: Healthy (36 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.